FIELD: medicine; cardiology; therapy; rehabilitation.
SUBSTANCE: invention can be used to predict the risk of atrial fibrillation in patients with obstructive sleep apnea syndrome. Determine the polymorphism of the HIF1 geneα. In the presence of the T/T genotype of the 1772C>T polymorphism (rs11549465) of the HIF1 geneα predict a high risk of developing atrial fibrillation in a patient.
EFFECT: method improves the accuracy of predicting the development of disease complications in patients with obstructive sleep apnea syndrome by determining the T/T rs11549465 genotype of the HIF1 geneα.
1 cl, 4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE PROGRESSION OF HEART FAILURE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2022 |
|
RU2796311C1 |
METHOD FOR PREDICTING THE ONE-YEAR RISK OF ADVERSE CARDIOVASCULAR EVENTS IN MEN AFTER DECOMPENSATION OF CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION AND OBSTRUCTIVE SLEEP APNEA SYNDROME | 2021 |
|
RU2767266C1 |
METHOD FOR DETERMINING RESPIRATORY, CARDIOVASCULAR AND METABOLIC DISORDERS RISK DEGREE IN PATIENTS SUFFERING FROM DESTRUCTIVE RESPIRATION DISORDERS IN SLEEPING | 2005 |
|
RU2308886C2 |
METHOD FOR PREDICTING THE PROGRESSION OF CHRONIC HEART FAILURE IN PATIENTS WITH BREAST CANCER AFTER ANTHRACYCLINE CHEMOTHERAPY | 2022 |
|
RU2790788C1 |
METHOD FOR DETERMINING THE PROBABILITY OF VISCERAL OBESITY IN A PATIENT WITH OBSTRUCTIVE SLEEP APNEA-HYPOPNEA BY FOUR ANTHROPOMETRIC SIGNS | 2020 |
|
RU2742798C1 |
METHOD FOR PERSONALIZED SELECTION OF PATIENTS WITH ANTHRACYCLINE-INDUCED CARDIOMYOPATHY AFTER POLYCHEMOTHERAPY OF BREAST CANCER FOR EFFECTIVE TREATMENT WITH CARVEDILOL | 2021 |
|
RU2778612C1 |
METHOD OF TREATING METABOLIC SYNDROM | 2010 |
|
RU2452523C1 |
METHOD FOR PREDICTION OF UNFAVOURABLE OUTCOME OF HYPERTROPHIC CARDIOMYOPATHY | 2013 |
|
RU2527768C1 |
METHOD FOR PREDICTING RISK OF DEVELOPMENT OF ISCHEMIC HEART DISEASE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2620545C1 |
METHOD FOR PREDICTING THE RISK OF PROGRESSING CHRONIC HEART FAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION | 2019 |
|
RU2734671C1 |
Authors
Dates
2023-04-04—Published
2022-08-17—Filed